FDA approves first biosimiar Zarxio

FDA approved filgrastim-sndz (Zarxio, Sandoz), the first biosimilar product approved in the United States. » Details

Drug shortages mobile app launched by FDA

FDA has launched its first mobile application (app) designed to provide quick access to important information on medications that are in short supply. Current or resolved drug shortages, as well as product discontinuations, can be identified by using the new app. » More

Continuing Education

New and emerging therapies for the treatment of diabetes

This month and next month pharmacists will be able to learn about the latest developments in diabetes treatment and management. Pharmacists can earn up to 4 hours of CPE credit with two monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to discuss new and emerging medications for the treatment of diabetes.

Read/print the article: Click here

Take the test: Click here to log in with the Session Code 15DT15-WKX27.

Announcement: Our CE activities have moved to a new learning management system to better serve you. The login to the Online CE Center is https://web2.uconn.edu/pharmacyce/login.php. All current user registration information has been uploaded for your convenience. Current users do not need to register. To review your registration page to ensure the data is up to date or to register, go to https://web2.uconn.edu/pharmacyce/program_register.php. For a full list of courses, go to http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

Lemtrada: A new therapy for patients who have had an inadequate response, intolerability to other multiple sclerosis drugs

Also: Pipeline agents for psychotherapeutic and neurological diseases. » Details

POLL:

A new class of biologics in the PCSK9 Inhibitors likely will be approved for treating high cholesterol. How are you preparing?

• New guidance on generic opioids, biosimilars labeling coming from FDA

• Managing medication shortages: The pharmacist's role

RESOURCES

Latest Clinical News